Mitulkumar A Patel
Overview
Explore the profile of Mitulkumar A Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patel M, Luthra S, Shamblin S, Arora K, Krzyzaniak J, Taylor L
Int J Pharm
. 2018 May;
546(1-2):226-234.
PMID: 29772284
Excipients are crucial components of most pharmaceutical formulations. In the case of a solid oral dosage formulation containing the salt form of a weakly ionizable drug, excipient selection is critical,...
2.
Patel M, Luthra S, Shamblin S, Arora K, Krzyzaniak J, Taylor L
Mol Pharm
. 2017 Dec;
15(1):40-52.
PMID: 29202237
Approximately 50% of solid oral dosage forms utilize salt forms of the active pharmaceutical ingredient (API). A major challenge with the salt form is its tendency to disproportionate to produce...
3.
Patel M, AbouGhaly M, Chadwick K
Int J Pharm
. 2017 Aug;
532(1):166-176.
PMID: 28847668
Understanding the phase behavior of crystal forms is essential in drug formulation development, as physical stability of the active pharmaceutical ingredient (API) is critical to achieving the desired bioavailability. Solvents...
4.
Patel M, AbouGhaly M, Schryer-Praga J, Chadwick K
Carbohydr Polym
. 2016 Oct;
155:362-371.
PMID: 27702523
The ability to engineer biocompatible polymers with controllable properties is highly desirable. One such approach is to cross-link carbohydrate polymers using ionotropic gelation (IG). Previous studies have investigated the effect...
5.
Kar S, Patel M, Tripathy R, Bajaj P, Pande A
Biochim Biophys Acta
. 2013 Aug;
1831(12):1714-20.
PMID: 23973798
Paraoxonase 1 (PON1) is an HDL-associated enzyme and exhibits anti-inflammatory, anti-diabetic, and anti-atherogenic properties. Association of PON1 to HDL particles increases the stability and activity of PON1 and is important...
6.
Kar S, Patel M, Tripathy R, Bajaj P, Suvarnakar U, Pande A
Biochim Biophys Acta
. 2012 May;
1821(9):1200-10.
PMID: 22634518
High density lipoprotein (HDL) particles are made up of lipid and protein constituents and apolipoprotein A-I (apoA-I) is a principal protein component that facilitates various biological activities of HDL particles....